Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells

Prostate

Volumn 71, Issue 2, 2011, Pages 157-167

  Zhang, Chu ^a   Soori, Mehrnoosh ^a   Miles, Fayth L ^a   Sikes, Robert A ^a   Carson, Daniel D ^b,c   Chung, Leland W K ^d   Farach Carson, Mary C ^a,b  

^a UNIVERSITY OF DELAWARE   (United States)

^b RICE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

apoptosis; bone metastasis; bone stroma; neuroendocrine differentiation; prostate cancer

Indexed keywords

BIOLOGICAL MARKER;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CANCER CELL; CANCER MORTALITY; CELL GROWTH; CELL STRAIN LNCAP; CELL TRANSDIFFERENTIATION; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HUMAN; MORBIDITY; MORPHOLOGY; NEUROENDOCRINOLOGY; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; STROMA CELL; TUMOR GROWTH;

APOPTOSIS; BLOTTING, WESTERN; BONE MARROW CELLS; BONE NEOPLASMS; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; NEUROENDOCRINE TUMORS; PROSTATIC NEOPLASMS; STROMAL CELLS;

EID: 78650978854     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21231     Document Type: Article

References (34)

1. Chung LW, Baseman A, Assikis V, Zhau HE,. Molecular insights into prostate cancer progression: The missing link of tumor microenvironment. J Urol 2005; 173 (1): 10-20.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. Cancer statistics, 2009. CA Cancer J Clin 2009; 59 (4): 225-249.
3. Chung LW, Huang WC, Sung SY, Wu D, Odero-Marah V, Nomura T, Shigemura K, Miyagi T, Seo S, Shi C, Molitierno J, Elmore J, Anderson C, Isotani S, Edlund M, Hsieh CL, Wang R, Shehata B, Zhau HE,. Stromal-epithelial interaction in prostate cancer progression. Clin Genitourin Cancer 2006; 5 (2): 162-170.
4. Huss WJ, Gray DR, Tavakoli K, Marmillion ME, Durham LE, Johnson MA, Greenberg NM, Smith GJ,. Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model. Neoplasia 2007; 9 (11): 938-950.
5. Zelivianski S, Verni M, Moore C, Kondrikov D, Taylor R, Lin MF,. Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype. Biochim Biophys Acta 2001; 1539 (1-2): 28-43. (Pubitemid 32522867)
6. Buijs JT, van der Pluijm G,. Osteotropic cancers: From primary tumor to bone. Cancer Lett 2008; 273 (2): 177-193.
7. Reddi AH, Roodman D, Freeman C, Mohla S,. Mechanisms of tumor metastasis to the bone: Challenges and opportunities. J Bone Miner Res 2003; 18 (2): 190-194.
8. Bussard KM, Gay CV, Mastro AM,. The bone microenvironment in metastasis; what is special about bone? Cancer Metastasis Rev 2008; 27 (1): 41-55.
9. Bonfil RD, Chinni S, Fridman R, Kim HR, Cher ML,. Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis. Urol Oncol 2007; 25 (5): 407-411.
10. Sikes RA, Nicholson BE, Koeneman KS, Edlund NM, Bissonette EA, Bradley MJ, Thalmann GN, Cecchini MG, Pienta KJ, Chung LW,. Cellular interactions in the tropism of prostate cancer to bone. Int J Cancer 2004; 110 (4): 497-503.
11. O'Connor JC, Farach-Carson MC, Schneider CJ, Carson DD,. Coculture with prostate cancer cells alters endoglin expression and attenuates transforming growth factor-beta signaling in reactive bone marrow stromal cells. Mol Cancer Res 2007; 5 (6): 585-603.
12. Knerr K, Ackermann K, Neidhart T, Pyerin W,. Bone metastasis: Osteoblasts affect growth and adhesion regulons in prostate tumor cells and provoke osteomimicry. Int J Cancer 2004; 111 (1): 152-159.
13. Taylor BS, Varambally S, Chinnaiyan AM,. A systems approach to model metastatic progression. Cancer Res 2006; 66 (11): 5537-5539.
14. Arnold RS, Sun CQ, Richards JC, Grigoriev G, Coleman IM, Nelson PS, Hsieh CL, Lee JK, Xu Z, Rogatko A, Osunkoya AO, Zayzafoon M, Chung L, Petros JA,. Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment. Prostate 2009; 69 (1): 1-11.
15. Fixemer T, Remberger K, Bonkhoff H,. Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma. Prostate 2002; 53 (2): 118-123.
16. Yang J, Fizazi K, Peleg S, Sikes CR, Raymond AK, Jamal N, Hu M, Olive M, Martinez LA, Wood CG, Logothetis CJ, Karsenty G, Navone NM,. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway. Cancer Res 2001; 61 (14): 5652-5659.
17. Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, Ozen M, Pathak S, Chung LW,. LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis. Prostate 2000; 44 (2): 91-103, Jul 101; 144 (102).
18. Roecklein BA, Torok-Storb B,. Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes. Blood 1995; 85 (4): 997-1005.
19. Muir C, Chung LW, Carson DD, Farach-Carson MC,. Hypoxia increases VEGF-A production by prostate cancer and bone marrow stromal cells and initiates paracrine activation of bone marrow endothelial cells. Clin Exp Metastasis 2006; 23 (1): 75-86.
20. Kaplan RN, Psaila B, Lyden D,. Bone marrow cells in the 'pre-metastatic niche': Within bone and beyond. Cancer Metastasis Rev 2006; 25 (4): 521-529.
21. Ribatti D, Mangialardi G, Vacca A,. Stephen Paget and the 'seed and soil' theory of metastatic dissemination. Clin Exp Med 2006; 6 (4): 145-149.
22. Lange PH, Vessella RL,. Mechanisms, hypotheses and questions regarding prostate cancer micrometastases to bone. Cancer Metastasis Rev 1998; 17 (4): 331-336.
23. Fisher JL, Schmitt JF, Howard ML, Mackie PS, Choong PF, Risbridger GP,. An in vivo model of prostate carcinoma growth and invasion in bone. Cell Tissue Res 2002; 307 (3): 337-345.
24. Perk H, Yildiz M, Kosar A, Cerci S, Soyupek F, Ozorak A, Dilmen C,. Correlation between BMD and bone scintigraphy in patients with prostate cancer. Urol Oncol 2008; 26 (3): 250-253.
25. Gomes RR Jr, Buttke P, Paul EM, Sikes RA,. Osteosclerotic prostate cancer metastasis to murine bone are enhanced with increased bone formation. Clin Exp Metastasis 2009; 26 (7): 641-651.
26. Dai J, Hall CL, Escara-Wilke J, Mizokami A, Keller JM, Keller ET,. Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms. Cancer Res 2008; 68 (14): 5785-5794.
27. Graf L, Iwata M, Torok-Storb B,. Gene expression profiling of the functionally distinct human bone marrow stromal cell lines HS-5 and HS-27a. Blood 2002; 100 (4): 1509-1511.
28. Lang SH, Miller WR, Habib FK,. Stimulation of human prostate cancer cell lines by factors present in human osteoblast-like cells but not in bone marrow. Prostate 1995; 27 (5): 287-293.
29. Cicek M, Oursler MJ,. Breast cancer bone metastasis and current small therapeutics. Cancer Metastasis Rev 2006; 25 (4): 635-644.
30. Abrahamsson PA,. Neuroendocrine differentiation in prostatic carcinoma. Prostate 1999; 39 (2): 135-148.
31. Hansson J, Abrahamsson PA,. Neuroendocrine differentiation in prostatic carcinoma. Scand J Urol Nephrol 2003; (212): 28-36.
32. Ayala GE, Dai H, Powell M, Li R, Ding Y, Wheeler TM, Shine D, Kadmon D, Thompson T, Miles BJ, Ittmann MM, Rowley D,. Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin Cancer Res 2008; 14 (23): 7593-7603.
33. Costa L, Major PP,. Effect of bisphosphonates on pain and quality of life in patients with bone metastases. Nat Clin Pract Oncol 2009; 6 (3): 163-174.
34. Smith MR,. Osteoclast targeted therapy for prostate cancer: Bisphosphonates and beyond. Urol Oncol 2008; 26 (4): 420-425.